Intraperitoneal Paclitaxel
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Intraperitoneal Paclitaxel, covering 2023-12-05 to 2026-02-02. Get the full timeline:
Most recent: Clinical Trial Update: Intraperitoneal Paclitaxel With NALIRIFOX for Pancreatic Ductal Adenocarcinoma With Peritoneal Carcinomatosis [Phase 1]